Jump to content

Gene Editing Patent Application Trends 2025: Difference between revisions

From WikiPatents
Newer edit →
Updating Gene Editing Patent Application Trends 2025
 
Updating Gene Editing Patent Application Trends 2025
Line 8: Line 8:
=== Top CPC Codes ===
=== Top CPC Codes ===
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
** Count: 79 patents
** Count: 91 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
** Count: 72 patents
** Count: 84 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
** Count: 48 patents
** Example: [[20250034558. COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES (Artisan Development Labs, Inc.)]]
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
** Count: 43 patents
** Count: 47 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
* [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available)
** Count: 41 patents
** Count: 41 patents
** Example: [[20250034558. COMPOSITIONS AND METHODS FOR TARGETING, EDITING OR MODIFYING HUMAN GENES (Artisan Development Labs, Inc.)]]
* [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available)
** Count: 38 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
** Count: 30 patents
** Count: 35 patents
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
** Example: [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]]
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
** Count: 30 patents
** Count: 33 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
* [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available)
* [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available)
** Count: 16 patents
** Count: 19 patents
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
** Example: [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]]
* [[:Category:CPC_A61K48/0058|A61K48/0058]] (No explanation available)
** Count: 19 patents
** Example: [[20250064978. GENE THERAPY METHODS FOR TREATMENT OF DIABETES (Jaguar Gene Therapy, LLC)]]
* [[:Category:CPC_C12N2800/80|C12N2800/80]] (No explanation available)
* [[:Category:CPC_C12N2800/80|C12N2800/80]] (No explanation available)
** Count: 13 patents
** Count: 15 patents
** Example: [[20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)]]
** Example: [[20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)]]
* [[:Category:CPC_A61K48/0058|A61K48/0058]] (No explanation available)
** Count: 13 patents
** Example: [[20250064978. GENE THERAPY METHODS FOR TREATMENT OF DIABETES (Jaguar Gene Therapy, LLC)]]


== Top Companies in Gene Editing 2025 ==
== Top Companies in Gene Editing 2025 ==
Line 42: Line 42:


=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
=== [[:Category:The Regents of the University of California|The Regents of the University of California]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 4
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_C07K16/2809|C07K16/2809]] (No explanation available): 1 patents
** [[:Category:CPC_C07K16/2809|C07K16/2809]] (No explanation available): 1 patents
Line 48: Line 48:
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 1 patents
* Recent patents:
* Recent patents:
** [[20250034251. ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES (The Regents of the University of California)]] (20250130)
** [[20250000945. Suppression of Neurodegeneration with Zinc Transporter Protein 7 (The Regents of the University of California)]] (20250102)
** [[20250000945. Suppression of Neurodegeneration with Zinc Transporter Protein 7 (The Regents of the University of California)]] (20250102)
** [[20250075175. EFFICIENT DERIVATION OF STABLE PLURIPOTENT BOVINE EMBRYONIC STEM CELLS (The Regents of the University of California)]] (20250306)
** [[20250049960. Multicomponent systems for site-specific genome modifications (The Regents of the University of California)]] (20250213)
** [[20250049960. Multicomponent systems for site-specific genome modifications (The Regents of the University of California)]] (20250213)
=== [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]] ===
* Number of Gene Editing patents: 4
* Top CPC codes:
** [[:Category:CPC_G01S7/4816|G01S7/4816]] (No explanation available): 1 patents
** [[:Category:CPC_G02B13/0055|G02B13/0055]] (No explanation available): 1 patents
** [[:Category:CPC_G02B13/008|G02B13/008]] (No explanation available): 1 patents
* Recent patents:
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
=== [[:Category:EmendoBio Inc.|EmendoBio Inc.]] ===
=== [[:Category:EmendoBio Inc.|EmendoBio Inc.]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 3
Line 61: Line 71:
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250051741. OMNI-103 CRISPR NUCLEASE (EmendoBio Inc.)]] (20250213)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
** [[20250011740. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 AND 262 CRISPR NUCLEASES (EmendoBio Inc.)]] (20250109)
=== [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]] ===
* Number of Gene Editing patents: 3
* Top CPC codes:
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 2 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 2 patents
** [[:Category:CPC_C12Q1/6823|C12Q1/6823]] (No explanation available): 1 patents
* Recent patents:
** [[20250034622. SMALL NOVEL CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF (THE BROAD INSTITUTE, INC.)]] (20250130)
** [[20250043366. TILED ASSAYS USING CRISPR-CAS BASED DETECTION (THE BROAD INSTITUTE, INC.)]] (20250206)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
=== [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]] ===
=== [[:Category:The Trustees of the University of Pennsylvania|The Trustees of the University of Pennsylvania]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 3
Line 81: Line 101:
** [[20250027087. MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE (CRISPR Therapeutics AG)]] (20250123)
** [[20250027087. MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE (CRISPR Therapeutics AG)]] (20250123)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
** [[20250011743. METHODS AND COMPOSITIONS FOR TREATING ANGIOPOIETIN-LIKE 3 (ANGPTL3) RELATED CONDITIONS (CRISPR Therapeutics AG)]] (20250109)
=== [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]] ===
=== [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 3
* Top CPC codes:
* Top CPC codes:
** [[:Category:CPC_G01S7/4816|G01S7/4816]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 2 patents
** [[:Category:CPC_G02B13/0055|G02B13/0055]] (No explanation available): 1 patents
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 2 patents
** [[:Category:CPC_G02B13/008|G02B13/008]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/8213|C12N15/8213]] (No explanation available): 2 patents
* Recent patents:
* Recent patents:
** [[20250044420. LENS FOR ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250206)
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
=== [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]] ===
=== [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 109: Line 129:
** [[20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)]] (20250130)
** [[20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)]] (20250130)
** [[20250027098. METHOD FOR SELECTING TARGET SITES FOR SITE-SPECIFIC GENOME MODIFICATION IN PLANTS (Monsanto Technology LLC)]] (20250123)
** [[20250027098. METHOD FOR SELECTING TARGET SITES FOR SITE-SPECIFIC GENOME MODIFICATION IN PLANTS (Monsanto Technology LLC)]] (20250123)
=== [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]] ===
* Number of Gene Editing patents: 2
* Top CPC codes:
** [[:Category:CPC_C12Q1/6823|C12Q1/6823]] (No explanation available): 1 patents
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 1 patents
** [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available): 1 patents
* Recent patents:
** [[20250034622. SMALL NOVEL CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF (THE BROAD INSTITUTE, INC.)]] (20250130)
** [[20250043366. TILED ASSAYS USING CRISPR-CAS BASED DETECTION (THE BROAD INSTITUTE, INC.)]] (20250206)
=== [[:Category:Caribou Biosciences, Inc.|Caribou Biosciences, Inc.]] ===
=== [[:Category:Caribou Biosciences, Inc.|Caribou Biosciences, Inc.]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 127: Line 138:
** [[20250034633. A METHOD OF CAPTURING CRISPR ENDONUCLEASE CLEAVAGE PRODUCTS (Caribou Biosciences, Inc.)]] (20250130)
** [[20250034633. A METHOD OF CAPTURING CRISPR ENDONUCLEASE CLEAVAGE PRODUCTS (Caribou Biosciences, Inc.)]] (20250130)
** [[20250027078. DNA-CONTAINING POLYNUCLEOTIDES AND GUIDES FOR CRISPR TYPE V SYSTEMS, AND METHODS OF MAKING AND USING THE SAME (Caribou Biosciences, Inc.)]] (20250123)
** [[20250027078. DNA-CONTAINING POLYNUCLEOTIDES AND GUIDES FOR CRISPR TYPE V SYSTEMS, AND METHODS OF MAKING AND USING THE SAME (Caribou Biosciences, Inc.)]] (20250123)
=== [[:Category:UCL BUSINESS LTD|UCL BUSINESS LTD]] ===
* Number of Gene Editing patents: 2
* Top CPC codes:
** [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available): 2 patents
** [[:Category:CPC_C12N2750/14143|C12N2750/14143]] (No explanation available): 2 patents
** [[:Category:CPC_A61K48/005|A61K48/005]] (No explanation available): 1 patents
* Recent patents:
** [[20250064974. ENDOGENOUS GENE REGULATION TO TREAT NEUROLOGICAL DISORDERS AND DISEASES (UCL BUSINESS LTD)]] (20250227)
** [[20250057899. GENE THERAPY FOR CILIOPATHIES (UCL BUSINESS LTD)]] (20250220)


== New Companies in Gene Editing (Last Month) ==
== New Companies in Gene Editing (Last Month) ==
Line 186: Line 188:


=== [[:Category:Chenglong HAO|Chenglong HAO]] ===
=== [[:Category:Chenglong HAO|Chenglong HAO]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 4
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 4 patents
* Recent patents:
* Recent patents:
** [[20250044420. LENS FOR ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250206)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
=== [[:Category:Fengze TAN|Fengze TAN]] ===
=== [[:Category:Fengze TAN|Fengze TAN]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 4
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 4 patents
* Recent patents:
* Recent patents:
** [[20250044420. LENS FOR ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250206)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
=== [[:Category:Jian ZHU|Jian ZHU]] ===
=== [[:Category:Jian ZHU|Jian ZHU]] ===
* Number of Gene Editing patents: 3
* Number of Gene Editing patents: 4
* Top companies:
* Top companies:
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 3 patents
** [[:Category:SHENZHEN METALENX TECHNOLOGY CO.,LTD|SHENZHEN METALENX TECHNOLOGY CO.,LTD]]: 4 patents
* Recent patents:
* Recent patents:
** [[20250044420. LENS FOR ToF (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250206)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250060582. DESIGN METHOD FOR METALENS, METALENS, SHAPING AND BEAM-COMBINATION DEVICE AND DISPLAY DEVICE (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250063841. METHOD FOR DESIGNING METALENS USED FOR IMAGE SENSOR (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250220)
** [[20250085533. OPTICAL SYSTEM AND OPTICAL CAMERA WORKING AT FAR-INFRARED WAVEBAND (SHENZHEN METALENX TECHNOLOGY CO.,LTD)]] (20250313)
=== [[:Category:Leida Rassouli-Taylor|Leida Rassouli-Taylor of Philadelphia PA (US)]] ===
=== [[:Category:Leida Rassouli-Taylor|Leida Rassouli-Taylor of Philadelphia PA (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 241: Line 243:
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.)]] (20250130)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
** [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)
=== [[:Category:Feng Zhang|Feng Zhang of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:THE BROAD INSTITUTE, INC.|THE BROAD INSTITUTE, INC.]]: 2 patents
* Recent patents:
** [[20250034622. SMALL NOVEL CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF (THE BROAD INSTITUTE, INC.)]] (20250130)
** [[20250075268. CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS (THE BROAD INSTITUTE, INC.)]] (20250306)
=== [[:Category:Alexandra Briner Crawley|Alexandra Briner Crawley of Cary NC (US)]] ===
=== [[:Category:Alexandra Briner Crawley|Alexandra Briner Crawley of Cary NC (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 255: Line 264:
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250066783. POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250227)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
** [[20250043315. RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE (LifeEDIT Therapeutics, Inc.)]] (20250206)
=== [[:Category:Andrew Garst|Andrew Garst of Pleasanton CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Inscripta, Inc.|Inscripta, Inc.]]: 2 patents
* Recent patents:
** [[20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250227)
** [[20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250306)
=== [[:Category:Ryan T. Gill|Ryan T. Gill of Pleasanton CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Inscripta, Inc.|Inscripta, Inc.]]: 2 patents
* Recent patents:
** [[20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250227)
** [[20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250306)
=== [[:Category:Tanya Elizabeth Warnecke Lipscomb|Tanya Elizabeth Warnecke Lipscomb of Pleasanton CA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:Inscripta, Inc.|Inscripta, Inc.]]: 2 patents
* Recent patents:
** [[20250066818. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250227)
** [[20250075232. NUCLEIC ACID-GUIDED NUCLEASES (Inscripta, Inc.)]] (20250306)
=== [[:Category:Eric B. Kmiec|Eric B. Kmiec of Middletown DE (US)]] ===
=== [[:Category:Eric B. Kmiec|Eric B. Kmiec of Middletown DE (US)]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 419: Line 449:
** [[20250019761. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250116)
** [[20250019761. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250116)
** [[20250011866. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250109)
** [[20250011866. METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING (UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION)]] (20250109)
=== [[:Category:ZHENGLIN HOU|ZHENGLIN HOU of ANKENY IA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]]: 2 patents
* Recent patents:
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250011804. INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250109)
=== [[:Category:JOSHUA K. YOUNG|JOSHUA K. YOUNG of JOHNSTON IA (US)]] ===
* Number of Gene Editing patents: 2
* Top companies:
** [[:Category:PIONEER HI-BRED INTERNATIONAL, INC.|PIONEER HI-BRED INTERNATIONAL, INC.]]: 2 patents
* Recent patents:
** [[20250075197. ENGINEERED DEAMINASES (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250306)
** [[20250027097. HIGH EFFICIENCY LARGE SCALE CHROMOSOMAL GENOME MANIPULATION (PIONEER HI-BRED INTERNATIONAL, INC.)]] (20250123)
=== [[:Category:Lior Izhar|Lior Izhar]] ===
=== [[:Category:Lior Izhar|Lior Izhar]] ===
* Number of Gene Editing patents: 2
* Number of Gene Editing patents: 2
Line 499: Line 543:
* Recent patents:
* Recent patents:
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
** [[20250032542. SYSTEMS AND METHODS FOR TRANS-MODULATION OF IMMUNE CELLS BY GENETIC MANIPULATION OF IMMUNE REGULATORY GENES (Targetgene Biotechnologies Ltd.)]] (20250130)
=== [[:Category:Khalid SHAH|Khalid SHAH of Andover MA (US)]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:THE BRIGHAM AND WOMEN'S HOSPITAL, INC.|THE BRIGHAM AND WOMEN'S HOSPITAL, INC.]]: 1 patents
* Recent patents:
** [[20250032611. GENE EDITING AND ENGINEERING STEM CELLS FOR DRUG DELIVERY (THE BRIGHAM AND WOMEN'S HOSPITAL, INC.)]] (20250130)
=== [[:Category:Andrew Baik|Andrew Baik of Scarsdale NY (US)]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
=== [[:Category:Katherine Cygnar|Katherine Cygnar of New York NY (US)]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
=== [[:Category:Leah Sabin|Leah Sabin of Goldens Bridge NY (US)]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
=== [[:Category:Poulami Samai|Poulami Samai of New York NY (US)]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)
=== [[:Category:Philip Calafati|Philip Calafati of Cambridge MA (US)]] ===
* Number of Gene Editing patents: 1
* Top companies:
** [[:Category:Regeneron Pharmaceuticals, Inc.|Regeneron Pharmaceuticals, Inc.]]: 1 patents
* Recent patents:
** [[20250032642. CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS (Regeneron Pharmaceuticals, Inc.)]] (20250130)


== Top Collaborations in Gene Editing ==
== Top Collaborations in Gene Editing ==
Line 546: Line 554:
[[File:Top_20_Cities_for_Gene_Editing_Inventors.png|border|800px]]
[[File:Top_20_Cities_for_Gene_Editing_Inventors.png|border|800px]]


* Cambridge: 28 inventors
* Cambridge: 35 inventors
* Shenzhen: 20 inventors
* Philadelphia: 19 inventors
* Shanghai: 19 inventors
* Shanghai: 19 inventors
* San Francisco: 17 inventors
* San Francisco: 18 inventors
* Philadelphia: 17 inventors
* Pleasanton: 17 inventors
* South Boston: 17 inventors
* South Boston: 17 inventors
* Shenzhen: 13 inventors
* San Diego: 14 inventors
* Pleasanton: 12 inventors
* Qingdao: 12 inventors
* Qingdao: 12 inventors
* New York: 11 inventors
* New York: 11 inventors
Line 558: Line 567:
* Oakland: 11 inventors
* Oakland: 11 inventors
* Boston: 10 inventors
* Boston: 10 inventors
* Milano: 10 inventors
* Rehovot: 9 inventors
* Rehovot: 9 inventors
* St. Louis: 9 inventors
* London: 9 inventors
* London: 9 inventors
* San Diego: 8 inventors
* Beijing: 8 inventors
* Beijing: 8 inventors
* Worcester: 7 inventors
* Worcester: 7 inventors
* CAMBRIDGE: 7 inventors
* Copenhagen: 7 inventors
* St. Louis: 7 inventors
* Tel Aviv: 7 inventors


[[Category:Gene Editing]]
[[Category:Gene Editing]]
[[Category:Patent Application Trends by Technology in 2025]]
[[Category:Patent Application Trends by Technology in 2025]]

Revision as of 03:05, 15 March 2025

Gene Editing Patent Application Filing Activity

Gene Editing patent applications in 2025

Error creating thumbnail: File missing

Top Technology Areas in Gene Editing

Top CPC Codes

Top Companies in Gene Editing 2025

The Regents of the University of California

SHENZHEN METALENX TECHNOLOGY CO.,LTD

EmendoBio Inc.

THE BROAD INSTITUTE, INC.

The Trustees of the University of Pennsylvania

CRISPR Therapeutics AG

PIONEER HI-BRED INTERNATIONAL, INC.

Regeneron Pharmaceuticals, Inc.

Monsanto Technology LLC

Caribou Biosciences, Inc.

New Companies in Gene Editing (Last Month)

File:New Companies in Gene Editing Last Month.png

No new companies detected in the last month.

Emerging Technology Areas in Gene Editing

Top Companies in Emerging Gene Editing Technologies 2025

Top Inventors in Gene Editing

Chenglong HAO

Fengze TAN

Jian ZHU

Leida Rassouli-Taylor of Philadelphia PA (US)

Lior IZHAR

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Liat ROCKAH

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Nir HECHT

  • Number of Gene Editing patents: 2
  • Top companies:
  • Recent patents:
    • 20250034596. Omni-103 CRISPR Nuclease-RNA Complexes (EmendoBio Inc.) (20250130)
    • [[20250011741. OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376, (EMENDOBIO INC)]] (20250109)

Feng Zhang of Cambridge MA (US)

Alexandra Briner Crawley of Cary NC (US)

Tedd D. Elich of Durham NC (US)

Andrew Garst of Pleasanton CA (US)

Ryan T. Gill of Pleasanton CA (US)

Tanya Elizabeth Warnecke Lipscomb of Pleasanton CA (US)

Eric B. Kmiec of Middletown DE (US)

Kelly H. Banas of Bear DE (US)

Joseph J. HIGGINS of Lexington MA (US)

Nancy CRAIG of Lexington MA (US)

Christopher BROWN of Albany CA (US)

Cindy CASTELLE of San Francisco CA (US)

Lisa ALEXANDER of Albany CA (US)

Yi-Shan Chen of South Boston MA (US)

Sandeep Soni of South Boston CA (US)

Laura Serwer of South Boston MA (US)

Jonathan Terrett of South Boston MA (US)

John Kulman of South Boston MA (US)

Benjamin OAKES of El Cerrito CA (US)

Sean HIGGINS of Alameda CA (US)

Sarah DENNY of San Francisco CA (US)

Brett T. STAAHL of Tiburon CA (US)

Isabel COLIN of Oakland CA (US)

Edwin Neumann of Somerville MA (US)

Tessa Bertozzi of Cambridge MA (US)

Jonathan Weissman of Cambridge MA (US)

Jesse Salk of Seattle WA (US)

Lawrence A. Loeb of Bellevue WA (US)

Michael Schmitt of Seattle WA (US)

ZHENGLIN HOU of ANKENY IA (US)

JOSHUA K. YOUNG of JOHNSTON IA (US)

Lior Izhar

Nadav Marbach Bar

Liat Rockah

Nurit Meron

Ophir Adiv Tal

Ariel Gispan

Idit Buch

Abdoulaye Ndao of Brookline MA (US)

Dan Michael WEINTHAL

Yoel Moshe SHIBOLETH

David STEINER

Talya KUNIK

Top Collaborations in Gene Editing

Top US States for Gene Editing Inventors


Top Cities for Gene Editing Inventors

  • Cambridge: 35 inventors
  • Shenzhen: 20 inventors
  • Philadelphia: 19 inventors
  • Shanghai: 19 inventors
  • San Francisco: 18 inventors
  • Pleasanton: 17 inventors
  • South Boston: 17 inventors
  • San Diego: 14 inventors
  • Qingdao: 12 inventors
  • New York: 11 inventors
  • Berkeley: 11 inventors
  • Oakland: 11 inventors
  • Boston: 10 inventors
  • Milano: 10 inventors
  • Rehovot: 9 inventors
  • St. Louis: 9 inventors
  • London: 9 inventors
  • Beijing: 8 inventors
  • Worcester: 7 inventors
  • Copenhagen: 7 inventors
Retrieved from "https://wikipatents.org/index.php?title=Gene_Editing_Patent_Application_Trends_2025&oldid=312667"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.